Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Temporary Codes Q0035-Q9992 > Cancer and Vision Associated Drugs Q5112-Q5134

2025 HCPCS code Q5112

Injection, trastuzumab-dttb, biosimilar, (Ontruzant), 10 mg

2025 HCPCS code Q5113

Injection, trastuzumab-pkrb, biosimilar (Herzuma®), 10 mg.

2025 HCPCS code Q5114

Injection, trastuzumab-dkst, biosimilar, (Ogivri), 10 mg

2025 HCPCS code Q5115

Injection, rituximab-abbs, biosimilar, (Truxima), 10 mg.

2025 HCPCS code Q5129

Injection, bevacizumab-adcd (Vegzelma), biosimilar, 10 mg.

2025 HCPCS code Q5118

Biosimilar bevacizumab-bvzr (Zirabev), 10 mg injection for intravenous infusion.

2025 HCPCS code Q5119

Rituximab-pvvr injection, 10 mg

2025 HCPCS code Q5132

Injection, adalimumab-afzb (Abrilada), biosimilar, 10 mg

2025 HCPCS code Q5133

This HCPCS code represents 1 mg of the tocilizumab biosimilar Tofidence™ (tocilizumab–bavi), used to treat rheumatoid arthritis or juvenile idiopathic arthritis.

2025 HCPCS code Q5126

Injection, bevacizumab-maly, biosimilar, (Alymsys), 10 mg